优化治疗耐火性铜缺乏症:一个案例报告
Bishara Jahshan1, Rami B Moussa2, Abdo Haddad3
1Internal Medicine, Winchester Medical Center, Winchester, USA.
Cureus
|March 11, 2026
概括
在Roux-en-Y胃绕道术后,铜缺乏是一个风险. 一种经过修改的静脉铜疗法,用更频繁的剂量,有效地治疗了对标准方案有抗性的患者.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 铜缺乏症是Roux-en-Y胃绕道手术后的一个新出现的并发症.
- 胃肠道吸收受损导致缺乏,表现为贫血,细胞衰竭和骨髓神经病变.
- 标准治疗包括口服或静脉注射 (IV) 铜, IV 首选用于吸收不良.
研究的目的:
- 在胃旁路术后的患者中报告一种耐治疗的铜缺乏病例.
- 为了突出标准IV铜补充方案的潜在不足.
- 建议针对耐火病例进行调整的IV铜治疗方案.
主要方法:
- 一个40多岁的女性的案例研究,她的病史是Roux-en-Y胃绕道和缺铁性贫血,呈现出麻醉症.
- 实验室评估证实了严重的铜缺乏 (血清铜:10μg/dL).
- 在标准的口服和静脉注射方案在两年内失败后,实施了修订的IV铜疗程 (每周两次2毫克).
主要成果:
- 患者表现出严重的铜缺乏,尽管最初的标准治疗.
- 标准的IV铜疗法 (每4-6周每5天每天2毫克) 在两年内无效.
- 调整后的治疗方案,每周两次输入2毫克铜,迅速使血清铜水平正常化.
结论:
- 标准的铜替代方案可能对一些胃绕道术后的患者来说不足.
- 增加IV铜的频率可以有效地治疗耐火铜缺乏症.
- 当标准方案在这种患者群体中失败时,个性化治疗策略至关重要.
更多相关视频
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
9.9K
09:23Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
10.3K
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
648
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
648
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
01:29Chronic Pancreatitis II: Collaborative Care
452
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
452